Delivery Order SPE2DU25D9415-SPE2DU26FEJCB
- Not listed
- The Defense Logistics Agency issued a $1,186.64 delivery order to DMS Pharmaceutical Group Inc. on March 7, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical products and medical consumables. DMS Pharmaceutical Group Inc. is a woman-owned small business. The PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract supporting pharmaceutical supply to Department of Defense military healthcare facilities worldwide, with a $499.9...
- The Defense Logistics Agency issued a $2,251.60 delivery order to DMS Pharmaceutical Group Inc. on March 9, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical supply. DMS Pharmaceutical Group Inc. is a woman-owned small business. The PPV-G GEN V is a Defense Logistics Agency single-award indefinite delivery contract with a $499.999 billion ceiling supporting pharmaceutical product distribution to military healthcare facilities worldwide....
- The Defense Logistics Agency issued a $65,066.40 delivery order to DMS Pharmaceutical Group Inc. on March 5, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical products and medical consumables. DMS Pharmaceutical Group Inc. is a woman-owned small business. The PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract supporting pharmaceutical supply to Department of Defense medical facilities worldwide; DMS Pharmaceutical Group's...
- The Defense Logistics Agency issued a $1,506.40 delivery order to DMS Pharmaceutical Group Inc. on March 4, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a Defense Logistics Agency single-award indefinite delivery contract with a $499.999 billion ceiling supporting pharmaceutical supply to Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group Inc. is a woman-owned small business pharmaceutical wholesaler. Place of performance...
- The Defense Logistics Agency issued a $1,557.44 delivery order to DMS Pharmaceutical Group Inc. on March 2, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical supply to federal military healthcare facilities. DMS Pharmaceutical Group Inc. is a woman-owned small business pharmaceutical wholesaler. The parent IDC, awarded to the awardee on November 13, 2025, carries a $499.99 billion ceiling and extends through December 31, 2036, with a...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on February 12, 2026, with a ceiling value of $13,420.80 for pharmaceutical supplies under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). DMS Pharmaceutical Group Inc. is a woman-owned small business. The delivery order is issued under the PPV-G GEN V IDC, a DLA single-award indefinite delivery contract with a $499.999 billion ceiling supporting pharmaceutical product distribution to...
- The Defense Logistics Agency issued a $1,322.93 delivery order to DMS Pharmaceutical Group Inc. on March 9, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical products and medical consumables. DMS Pharmaceutical Group Inc. is a woman-owned small business. The order is firm fixed price with place of performance in Park Ridge, IL. The ultimate completion date is March 9, 2026. PPV-G GEN V is a Defense Logistics Agency indefinite delivery...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on March 4, 2026, with a ceiling value of $13,522.81 for pharmaceutical products under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). DMS Pharmaceutical Group Inc. is a woman-owned small business pharmaceutical wholesaler. Place of performance is Park Ridge, IL. The order is issued under the PPV-G GEN V, a Defense Logistics Agency indefinite delivery contract supporting...
- The Defense Logistics Agency issued a $1,526.64 delivery order to DMS Pharmaceutical Group Inc. on March 4, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical products supporting defense medical supply needs. DMS Pharmaceutical Group Inc. is a woman-owned small business pharmaceutical wholesaler. The order is firm fixed price with place of performance in Park Ridge, IL 60068. Ultimate completion date is March 5, 2026. PPV-G GEN V is a...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on March 5, 2026, with a ceiling value of $42,581.50 for pharmaceutical products and medical consumables under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). DMS Pharmaceutical Group is a woman-owned small business pharmaceutical wholesaler. The delivery order is issued under the PPV-G GEN V indefinite delivery contract, a Defense Logistics Agency program that establishes regional...
- SPE2DU25D9415Indefinite Delivery Contract
- SPE2DU25D9415-SPE2DU26FEJCBDelivery Order
The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on March 10, 2026, for pharmaceutical products under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), with a ceiling value of $4,361.95. DMS Pharmaceutical Group is a woman-owned small business pharmaceutical wholesaler. The order is placed against the company's single-award Indefinite Delivery Contract under the Defense Logistics Agency's PPV-G GEN V initiative, a $499.999 billion program supporting Department of Defense medical supply needs globally with a contract completion date of December 31, 2036. Place of performance is Park Ridge, Illinois. The delivery order ultimate completion date is March 24, 2026. Pricing is firm fixed price.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.4k | 3/9/26 |